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biochemical consequences of PrPSc structural heterogeneity during prion replication and 1 propagation are poorly understood. 2 Maybe one of the most intriguing and unpredictable change in prion replicative environment is 3 the interspecies transmission. In certain host/strain combinations, prions will propagate readily 4 as in an intraspecies transmission. In other host/strain combinations, only a fraction of the 5 exposed animals will develop the disease with variable incubation periods, reflecting a 'species' 6 or 'transmission' barrier. Attaining full attack rate and minimal incubation periods will require 7 iterative transmissions. At that stage, prions are considered to be adapted to the new host [3] . 8
Two main theoretical models have been developed to describe the transmission barrier at the 9 molecular level. Both propose that the species barrier is governed by a misfit between PrPSc 10 contained in the infecting prion and host PrPC folding landscape [5, 24] . Schematically, the first 11 one called 'deformed templating' consider that PrPC will progressively adopt, -due to its 12 specific conformational dynamic-, the "quasi-right" conformation to be selected during the 13 templating process [24] . As a consequence, a switch to a new strain structural determinant can 14 occur, which combines structural information from the inoculated PrPSc assemblies with the 15 folding landscape of the new host PrPC [25] [26] [27] [28] [29] . A major limitation of this model resides in the 16 assumption that all PrPSc assemblies are structurally equivalent, despite experimental counter-17 evidence. The second model called 'conformational selection' considers the existence of 18 structurally distinct PrPSc subsets within a strain or isolate, the species adaptation resulting from 19 the selection of the best replicator [5] . The two models are not mutually exclusive. They at least 20 7 | survival times of the inoculated fractions in infectious dose (i.e., equivalent to that found in 1 brain homogenate dilutions) as estimate of infectivity. 2
Immunoblots 3
Aliquots of the collected fractions were treated with a final concentration of 50 µg/ml PK (1 4 hour, 37°C). Samples were then mixed in Laemmli buffer and denatured at 100°C for 5 min. 5
The samples (15 µl) were run on 12% Bis-Tris Criterion gels (Bio-Rad, Marne la Vallée, 6 France) and analyzed by immunoblots, using the Sha31 anti-PrP antibody (human PrP epitope 7 at residues 145 to 152 [35] ). Immunoreactivity was visualized by chemiluminescence (GE 8 Healthcare). The amount of PrP present per fraction and the PrPSc glycoforms ratios were 9 determined with the GeneTools software after acquisition of chemiluminescent signals with a 10 GeneGnome digital imager (Syngene, Frederick, Maryland, United States). 11
Histoblots 12
For histoblotting procedure, brains were rapidly removed from euthanized mice and frozen on 13 dry ice. Cryosections were cut at 8-10 m, transferred onto Superfrost slides and kept at -20°C 14 until use. Histoblot analyses were performed on 3 brains per experiment, using the 12F10 anti-15 PrP antibody (human PrP epitope at residues 145 to 160 [36] ). 16
Results

17
Transgenic modelling of prion species barrier 18 We used a previously developed SV protocol to separate different populations of PrPSc 19 assemblies according to their quaternary structure [13, 15, 18] . To determine the potential role 20 of the SV-isolated PrPSc subpopulations in prion adaptation and evolution, we included in the 21 present study three well-characterized ovine prion strains termed LA19K, LA21K fast and 22 127S. These cloned strains markedly differ according to the specific infectivity of their 23 respective PrPSc subpopulations in the homotypic PrP transmission conditions. For LA21K fast 24 and 127S strains, a discrete population of small oligomers (<pentamers) exhibit the highest 8 | specific infectivity values. For LA19K, the highest specific infectivity values are associated 1 with larger-size oligomers (>40 PrP-mers) [23] . We also included atypical L-BSE prions in the 2 study, because of their mutability on cross-species transmission [37] . 3
We transmitted SV fractionated-PrPSc assemblies from the aforementioned strains to transgenic 4 mouse models expressing heterotypic PrP. The models were chosen according to the 5 transmission barrier observed with unfractionated material, as examined by gold-standard 6 criteria [38] [39] [40] , including disease attack rate on primary passage, reduction of incubation 7 durations (ID) on serial passaging, and establishment of prion strain properties. The same 8 analyses were performed on back-passage to mice expressing the parental host PrPC. For the 9 sake of clarity, these data are comprehensively summarized as Additional file 1, supplementary 10 text and supplementary Fig. 1-4 . However, to provide a straightforward estimator of the 11 stringency of the species barrier, we used the reduction factor between the mean ID on first to 12 second passage in the heterotypic context and on retrotransmission [40] . These data are shown 13 as Fig. 1a . A magnitude of 1 signifies prion straight adaptation. As model of prion transmission 14 without species barrier, LA19K scrapie prions from ovine PrP (tgOv) mice was passed to 15 bovine PrP mice (tgBov). As model of prion transmission with species barrier and 'mutation', 16
we passed L-BSE prions onto tgOv mice. As models of prion transmission with strong species 17 barrier, we passed LA21K fast and 127S scrapie prions onto hamster PrP mice (tgHa). 18
Impact of size-fractionation on prion pathogenesis in the heterotypic PrP context 19
Brain homogenates from tgOv mice containing LA19K prions, LA21K fast or 127S prions and 20 from cattle containing L-BSE prions were solubilized and fractionated by SV [15, 18] . The 21 fractions were then intracerebrally inoculated in the heterotypic PrPC context to determine the 22 specific transmission propensity of each fraction. (Fig. 1b ). As controls, some fractions were 23 transmitted in the homotypic PrP context and confirmed our previous results ( [18] ; vide infra).
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In the absence of any apparent species barrier, as determined for LA19K inoculated to tgBov 1 mice, the infectivity sedimentograms in the homotypic and heterotypic passage conditions, 2 tended to superimpose, in terms of distribution and infectivity values amongst the fractions 3 ( Fig. 2a ). Each LA19K isolated PrPSc assembly thus exhibited quasi-equivalent specific 4 infectivity in both transmission contexts. The strain-specified PrPres electrophoretic profile and 5 pattern of cerebral PrPres deposition [33] were conserved amongst the tgBov mice inoculated 6 with the different fractions or unfractionated LA19K brain material ( Fig. 2b and additional file 7 1, supplementary Fig. 5 ), suggesting phenotypic invariance of the isolated LA19K assemblies 8 on heterotypic transmission. 9
In the presence of a strong species barrier, as determined for LA21K fast and 127S inoculated 10 to tgHa mice, SV-fractionation had a strong negative impact. None of the mice inoculated with 11 the fractions from three independent gradients developed any neurological symptoms up to end-12 life. Only 3 out of the 221 tested mice (i.e., 1%) accumulated PrPres in the brain. These 3 mice 13 were inoculated with fractions 10 and 13 from one LA21K fast gradient ( Fig. 2 , Table 1 ). In 14 particular, none of the tgHa mice inoculated with the PrPSc assemblies with the highest specific 15 infectivity values from fractions 1-2 accumulated any detectable PrPres (n=43, Table 1 ). These 16 results were confirmed by a second passage with individual or pooled (by 2) tgHa brains, 17 covering the entire LA21K fast gradient. All the secondary transmissions with PrPres-negative 18 brains were negative (neurological signs and PrPres; To discard the possibility that the loss of tgHa-transmissibility of the isolated PrPSc was due to 24 an insufficient infectivity load, we estimated the infectivity levels of the top and middle 25 fractions of one LA21K fast gradient. Fractions 2 and 12 induced disease in tgOv mice in 68 ± 1 3 days (5/5) and 82 ± 1 days (5/5), respectively ( Fig. 3a) , meaning, according to LA21K fast 2 dose/response curve ( Fig. 3a , Table 3 ), that their infectivity levels were equivalent to 10-1.2 and 3 10-3.2 dilutions of LA21K fast brain material, respectively. These values were fully consistent 4 with the mean (SEM) relative infectious dose contained in LA21K fast most infectious upper 5 fractions and middle fractions established from seven independent bioassays (top fractions: 6 mean: 10-1.36 (10-1.08 to 10-1.64); middle fractions: between 10-2.9 and 10-4.65 depending on the 7 middle fractions). To estimate the infectivity load of these factions in the heterotypic PrP 8 context, we established a dose/response curve of LA21K fast in tgHa mice by transmitting by 9 intracerebral route serial tenfold dilutions of a LA21K fast tgOv-brain to reporter tgHa mice. 10
The limiting dilution value of LA21K fast prions in tgHa mice was surprisingly low (vide infra), 11 establishing at 10-2 (Table 3) . Nevertheless, this value was below the infectivity value of the 12 top fractions of the gradient. Those were thus sufficiently infectious per se to induce or transmit 13 disease, at least partly in tgHa mice. This was not observed in 3 independent experiments with 14 a sufficient number of inoculated mice. Almost counterintuitively, the sole fractions eliciting 15 asymptomatic replication in a very low number of mice had infectivity values below the limiting 16 dilution. This suggests a stochastic transmission process and lends support to the view that 17 infection is possible at doses below the limiting dilution [44]. 18
Together, these observations indicate that PrPSc subassemblies segregation by SV-fractionation 19 alters their replication efficiency in the PrP transmission barrier context, for reasons 20 independent of their infectivity load. This suggests synergetic interactions between PrPSc 21 subsets for an efficient heterospecies transmission. 22
Dilution of LA21K fast prion-infected brain homogenate strengthens existing 1 transmission barriers 2 LA21K fast prions are composed of at least two structurally PrPSc subsets in different 3 proportion, each with distinct specific infectivity [23, 15, 18] . Dilution experiments constitute a 4 relevant method to explore the contribution of each PrPSc subtype. Over a certain dilution factor, 5
the minor population will be quasi-eliminated from the inoculum leading to explore the effect 6 of the major species. The dilution approaches should also allow dissociating biochemical 7 complex(es) between different PrPSc subsets due to equilibrium displacement toward 8 dissociation [13]. 9
We thus further analyzed the titration of LA21K fast prions in tgHa mice. Neat brain 10 homogenate (20 L 10%) containing LA21K fast prions induced disease in all tgHa mice with 11 a mean ID of 153 days (Table 3 ; Additional file 1., supplementary Fig. 3a ). At the 10-1 dilution, 12 the mean ID increased to 181 days (6/6 mice affected). The limiting dilution value resulting in 13 positive transmission established at the 10-2 dilution, with 2 out of 6 tgHa mice developing the 14 disease at 192 and 230 days (Table 3 ). In homotypic transmission, LA21K fast limiting dilution 15 value established at 10-7 (Table 3) . There was thus a considerable 105-fold reduction of this 16 value in the heterotypic PrP transmission context. For comparison, in the absence of a 17 transmission barrier, as for LA19K prions in tgBov mice, there was no significant variations in 18 the limiting dilution value between the homotypic and heterotypic contexts (Table 3) . 19
The inefficacy of LA21K fast diluted material to infect tgHa mice appeared further discrepant 20 when considering the fold increase between the IDs at the lowest and at the limiting dilution. 21
There was here a 1.37-fold increase for LA21K fast in tgHa mice (from 153 to 211 days, Table  22 3) whereas the meanSD fold increase value observed in all the titrations we performed so far 23 in our laboratory in homotypic conditions, including in tgHa mice, was statistically higher at 24 tgHa mice would result in a theoretical limiting dilution value at 10-5 and a 330 days ID ( Fig.  1 4b). 2 Collectively, these data suggest that the dilution leads to the quasi elimination of at least one 3 compound and/or the dissociation of a complex mandatory for the efficacy of the heterotypic 4 transmission and consolidate our SV-based observations. 5
PrPC level and/or tissue environment imposes the species barrier stringency 6
When isolated L-BSE SV-fractions were transmitted to tgOv mice, only fractions 8 to 14 7 induced disease at complete or near-complete attack rate, with an overt delay compared to 8 unfractionated material ( Fig. 5a , Table 4 ). Mice inoculated with the top and bottom fractions 9 transmitted the disease only erratically, suggesting unfavorable transmission conditions ( Fig.  10 5a, Table 4 ). Isolated L-BSE assemblies had therefore altered transmission capacities in the 11 heterotypic PrP transmission context, as observed with LA21K fast and 127S. The western blot 12 profile on primary passage ( Fig. 5b ) and the strain phenotype obtained on 2nd passage with 13
PrPres-positive mouse brains indicated that C-BSE like prions has emerged from all positive 14 transmissions (Additional File 1, supplementary Fig. 5 ; supplementary Table 1) . 15
Previously, we reported that lymphotropic prions replicated easier in the spleen than in the brain 16 in both homotypic and heterotypic PrP context, despite 20-fold lowered PrPC levels [27, 45] . 17
This makes bioassays based on prion detection in the mouse spleen a highly sensitive method 18 to detect low dose of lymphotropic prions [45] . We thus examined further the capacity of SV-19 fractionated L-BSE prions to propagate in the heterotypic PrP context by examining tgOv 20 spleens for PrPres content after inoculation with the different fractions. Of the 49 tgOv spleens 21 analyzed, only 3 (6%) accumulated low levels of PrPres (Table 4 ). Of the 13 mice for which 22 both the brains and spleens were analyzed for PrPres content and the brain was positive (notably 23 fractions 10-12 with 100% attack rate), only 3 had also positive spleens (23%). For comparison, all the spleens analyzed after inoculation of unfractionated L-type prions were strongly PrPres-1 positive from the first passage onward ( Strikingly, prion replication in the spleen was still altered on secondary passage of SV-3 fractionated L-BSE assemblies. While all the spleens analyzed (n=15) were PrPres-positive, the 4 levels of accumulation were still reduced by ~4-fold as compared to those observed on serial 5 transmission of unfractionated material ( Fig. 6a-b ). It may be noted that in homotypic 6 transmissions, fractionating brain material had no significant influence on spleen colonization 7 by prions, with regards to the number of positive spleens and PrPres accumulation levels ( Fig.  8 6b), indicating that, alone, the size of the infectious particles or PrPSc subpopulation segregation 9
were not causal. Therefore, we can conclude from the impairment observed over two serial 10 passages that the low barrier penetrance of the isolated fractions is not due to a low infectivity 11 load and that size fractionation impairs L-BSE replication in the spleen to an extent that is 12 higher than in the brain. 13 14
Discussion
15
As conventional pathogens, prions are subject to adaptation and evolution. The concept of 16 molecular quasispecies, as defined by Eigen in 1979 [47], has been applied to prions [5, 48] to 17 reconcile the structural diversity of prion assemblies (i.e. prion structural landscape) to the 18 preferential selection based on the 'best replicator' selection concept of certain subassemblies 19 during prion adaptation to new host or to a new environment/replicative conditions [49, 27] . To 20 refine this 'best replicator' hypothesis [50], we tested the capacity of isolated PrPSc 21 subassemblies within a given prion strain to adapt to a new host. We show here with multiple 22
PrP transgenic mouse models inoculated with both field-derived and biologically cloned prions, 23 that cross-species prion transmission does not strictly involve the selection of an existing 24 subpopulation of optimized PrPSc assemblies. Rather, our observations suggest that the key 1 determinant is a synergy between structurally distinct PrPSc subassemblies. 2 3 There was a positive correlation between the magnitude of the transmission barrier and the 4 difficulty for SV-individualized PrPSc assemblies to transmit the disease in the heterotypic PrP 5 conditions. L-BSE prions fractionation significantly delayed priogenesis in the brain and even 6 more negatively in the spleen of the challenged tgOv mice. Fractionated LA21K fast scrapie 7 prions replicated asymptomatically in a very small proportion of tgHa mice and fractionated 8
127S prions failed to propagate in these mice. As shown previously and also demonstrated here, 9
LA21K fast and 127S scrapie prion strains are composed of at least two structurally distinct 10
PrPSc subpopulations according to their specific infectivity values ( Fig. 3a and [15,18 ,23]). The 11 loss of transmissibility of separately taken PrPSc assemblies to tgHa mice cannot be attributed 12 to a global decrease of infectivity levels due to the solubilization/fractionation method as we 13 previously reported that the cumulated infectivity of the SV fractions did not differ significantly 14 from that present in the loaded material [18] . Further, for LA21K fast, the relative infectivity 15 titer of the top 'most infectious' fractions was sufficiently high to induce disease in tgHa. The 16 fact that PrPSc assemblies segregation affects prion heterospecies transmission suggests a 17 synergy between PrPSc subassemblies to overcome the species barrier. This hypothesis 18
implicates an unprecedented notion of complementation between structurally distinct prion 19 assemblies. 20
While the molecular mechanisms of such synergy between different PrPSc subsets remain to be 21 elucidated, some simple biochemical considerations can bring basements on the biochemistry 22 of the process. It implicates interactions between structurally distinct PrPSc subsets in order to 23 create a new structural information absent in each individual PrPSc population and leading to 24 heterologous PrPC integration. During the early stage of prion replication, we showed that two 25 sets of structurally distinct PrPSc assemblies are generated, in fractions 1-5 and 10-18 [20] . 1 These sets are defined by their elementary subunit [13] as suPrPA and suPrPB, respectively [27] . 2 During the early step of prion replication, suPrPA and suPrPB form a suPrPA:suPrPB 3 heterocomplex involved in a secondary autocatalytic templating process generating de novo the 4 formation of suPrPB, in a PrPC-dependent manner [27] . The synergetic effect between different 5
PrPSc subsets can reside in the formation of this complex, making therefore this secondary 6 templating process a pivot of prion adaptation to a new host. In the heterotypic PrP transmission 7 context, the suPrPA:suPrPB complex (likely present in the inoculum) may incorporate 8 heterologous PrPC, leading to the formation of a de novo suPrPB* formed by the heterologous 9
PrPC with a new templating interface different from the inoculum suPrPB (Fig. 7) . This first 10 event would be a limiting step of the adaptation process. The entrance of suPrPB* in the 11 autocatalytic cycle makes its formation highly cooperative. Based on these assumptions, if the 12 stability of the complex is high enough (i.e., low dissociation constant), the reconstitution of The existence of a complex such as suPrPA:suPrPB within the inoculum is further supported by 20 the striking observation that endpoint dilutions aberrantly impaired LA21K fast prions transfer 21 to tgHa mice (1000-fold decreased efficacy); the dilution steps would make certain PrPSc heterotypic PrP (blue line) transmission context. Brain homogenates from tgOv mice inoculated with LA19K prions were solubilized before fractionation by SV. The collected fractions were 1 analyzed for PrPres content by immunoblot and for infectivity by an incubation time bioassay in 2 tgOv and tgBov mice (tg110 line). In the homotypic context, plain and dotted symbols/lines 3 refer to this study and to previous reports [18] , respectively. The right logarithmic brown scale 4 provides the LA19K-specific reciprocal relation between survival time in tgOv and tgBov mice 5 and infectious dose, as established by limiting dilution titration (as from Table 3 and [18] ). 6
Animals inoculated with 10% infectious brain material are assigned an infectious dose of 0. Survival time2 (n/n0)3 
